Report updated Apr 23, 2026
FreeStyle LibreLink - US
For individuals with diabetes who use FreeStyle Libre sensors and require a digital tool to track and share glucose data.
FreeStyle LibreLink - US is a struggling medical app that is completely free. With a 2.9/5 rating from 3.3K reviews, it struggles with user retention. Users particularly appreciate hardware quality, though os & device compatibility remains a common concern.
What is FreeStyle LibreLink - US?
Current Momentum
v2.13 · 1w ago
MaintenanceFreeStyle LibreLink - US is currently in maintenance mode with no recent major feature updates identified.
Active Nemesis
Dexcom G7
By Dexcom
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Painless glucose monitoring by holding the phone near a sensor, replacing routine fingersticks.
Generates detailed glucose reports and visual patterns to help users understand health trends.
Connects and shares glucose data directly with healthcare professionals.
How much does it cost?
- Free app usage with required hardware sensor purchase
The app follows a hardware-companion model where monetization is entirely dependent on the recurring purchase of physical sensors rather than digital subscriptions.
Who Built It?
Abbott Labs
Providing digital health tools for continuous glucose monitoring. Enabling patients to track glucose trends via smartphone integration.
Portfolio
13
Apps
What other apps does Abbott Labs make?
Libre by Abbott
FreeStyle Libre 3 – US
FreeStyle LibreLink – ZA
FreeStyle LibreLink – BE
FreeStyle LibreLink – KW
FreeStyle Libre 3 - CH
Explore the full Abbott Labs report
Portfolio breakdown, audience, momentum, and every app published by Abbott Labs.
What do users think recently?
High confidence · Latest 100 of 3.3K total reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. Users appreciate hardware quality, but report os & device compatibility and app performance & stability.
What Users Love
What Frustrates Users
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for FreeStyle LibreLink - US?
How's The Medical Market?
Market outlook for this category
Available very soon
The rivals identified
The outtake for FreeStyle LibreLink - US
Strengths to defend, gaps to attack
Core Strengths
- Proprietary NFC scanning technology
- Direct clinical integration via LibreView
- Strong hardware-software synergy
Critical Frictions
- Critical iOS 18/iPhone 16 compatibility issues
- Severe UI lag and performance degradation
- Missing Dark Mode and Apple Health integration
Growth Levers
- Native Apple Watch support to match Dexcom
- AI meal tracking integration (SNAQ model)
- Collaborative care features (Gluroo model)
Market Threats
- Dexcom G7's superior update velocity and 30-min warm-up
- User churn due to technical instability on new devices
- Hardware-agnostic aggregators capturing the data layer
What are the next best moves?
Immediate Hotfix for iOS 18 & iPhone 16 Compatibility
This is the #1 complaint theme and a total blocker for users on new hardware, leading to a 'terrible' sentiment rating.
Implement Apple Health & Apple Watch Integration
Dexcom G7 offers native Watch support and users explicitly cite the lack of Apple Health as a major frustration.
Performance Optimization Sprint
Users report 30-second input lags and frequent freezing, indicating severe technical debt or memory leaks.
Feature Gaps vs Competitors
- Native Apple Watch integration (available in Dexcom G7)
- 30-minute sensor warm-up (Dexcom G7 has this; LibreLink requires 60 mins)
- AI Food Tracking/Computer Vision (available in SNAQ)
- Bolus Calculator (available in mySugr)
Key Takeaways
FreeStyle LibreLink is currently a high-quality hardware product trapped in a failing software wrapper. While the NFC scanning remains a core strength, the app's inability to support current iOS versions and its lack of modern ecosystem features (Watch/Health) make it highly vulnerable to Dexcom G7.
Where Is It Heading?
Declining
Critical failures on iOS 18 and iPhone 16 reported by high volume of users.
Severe performance lag (30s input delay) suggesting unaddressed technical debt.
Recent updates limited to generic bug fixes with no new feature expansion.